Javascript must be enabled to continue!
Impact of Early Allograft Dysfunction on Renal Function Outcomes Following Liver Transplantation
View through CrossRef
Background and Objectives: Early allograft dysfunction (EAD) after liver transplantation (LT) is associated with adverse graft and patient outcomes. However, its effects on kidney outcomes remain unclear. We retrospectively investigated the association between EAD and various kidney events following LT. Materials and Methods: We included 92 LT recipients. EAD was defined by the presence of ≥1 of the following: total bilirubin level ≥ 10 mg/dL or international normalized ratio ≥ 1.6 on postoperative day 7, or aspartate aminotransferase or alanine aminotransferase level > 2000 U/L within the first 7 days post-LT. Kidney outcomes included acute kidney injury (AKI), acute kidney disease (AKD), kidney replacement therapy (KRT) performance, and changes in estimated glomerular filtration rate (eGFR). Results: AKI incidence was comparable between the non-EAD and EAD groups; however, stage 3 AKI incidence was higher in the EAD group (65.0% vs. 22.2%; p = 0.001). AKD occurred more frequently in the EAD group (75.0% vs. 30.6%, p = 0.001). KRT was required more frequently within 7 days of LT in the EAD group (70.0%) than in the non-EAD group (15.3%) (p < 0.001). Multivariate analysis identified EAD as an independent predictor of KRT requirement (p < 0.001). EAD was associated with prolonged (≥7 days) KRT requirement (p = 0.025). In the receiver operating characteristic curves, all EAD components were associated with KRT requirement following LT. The baseline and 3-month eGFR levels were comparable; however, a trend toward a steeper decline was noted in eGFR in the EAD group than that in the non-EAD group (p = 0.090). The burden of hospitalization and calcineurin inhibitor exposure were similar between the groups. Conclusions: EAD appears to be independently associated with adverse kidney outcomes following LT. Preventive strategies targeting EAD are required to improve post-transplant prognosis and mitigate kidney-related complications.
Title: Impact of Early Allograft Dysfunction on Renal Function Outcomes Following Liver Transplantation
Description:
Background and Objectives: Early allograft dysfunction (EAD) after liver transplantation (LT) is associated with adverse graft and patient outcomes.
However, its effects on kidney outcomes remain unclear.
We retrospectively investigated the association between EAD and various kidney events following LT.
Materials and Methods: We included 92 LT recipients.
EAD was defined by the presence of ≥1 of the following: total bilirubin level ≥ 10 mg/dL or international normalized ratio ≥ 1.
6 on postoperative day 7, or aspartate aminotransferase or alanine aminotransferase level > 2000 U/L within the first 7 days post-LT.
Kidney outcomes included acute kidney injury (AKI), acute kidney disease (AKD), kidney replacement therapy (KRT) performance, and changes in estimated glomerular filtration rate (eGFR).
Results: AKI incidence was comparable between the non-EAD and EAD groups; however, stage 3 AKI incidence was higher in the EAD group (65.
0% vs.
22.
2%; p = 0.
001).
AKD occurred more frequently in the EAD group (75.
0% vs.
30.
6%, p = 0.
001).
KRT was required more frequently within 7 days of LT in the EAD group (70.
0%) than in the non-EAD group (15.
3%) (p < 0.
001).
Multivariate analysis identified EAD as an independent predictor of KRT requirement (p < 0.
001).
EAD was associated with prolonged (≥7 days) KRT requirement (p = 0.
025).
In the receiver operating characteristic curves, all EAD components were associated with KRT requirement following LT.
The baseline and 3-month eGFR levels were comparable; however, a trend toward a steeper decline was noted in eGFR in the EAD group than that in the non-EAD group (p = 0.
090).
The burden of hospitalization and calcineurin inhibitor exposure were similar between the groups.
Conclusions: EAD appears to be independently associated with adverse kidney outcomes following LT.
Preventive strategies targeting EAD are required to improve post-transplant prognosis and mitigate kidney-related complications.
Related Results
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Does the Presence of Renal Vascular Variation in the Renal Allograft Determine the Outcome of Renal Transplantation? Experience from the National Kidney Transplantation Center, Ethiopia
Does the Presence of Renal Vascular Variation in the Renal Allograft Determine the Outcome of Renal Transplantation? Experience from the National Kidney Transplantation Center, Ethiopia
Abstract
Background: Renal transplantation is the treatment of choice for people who suffer from end stage renal disease. Renal vascular anatomy is known for presenting a w...
Allograft nephrectomy vs. no‐allograft nephrectomy for renal transplantation: a meta‐analysis
Allograft nephrectomy vs. no‐allograft nephrectomy for renal transplantation: a meta‐analysis
AbstractObjectiveTo assess the safety and efficacy of allograft nephrectomy vs. no‐allograft nephrectomy for renal re‐transplantation.MethodsMedline (PubMed), Embase, Ovid, Cochran...
PB1673 FEASIBILITY AND OUTCOME OF ALLOGENEIC BONE MARROW TRANSPLANTATION IN ADULT PHI NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
PB1673 FEASIBILITY AND OUTCOME OF ALLOGENEIC BONE MARROW TRANSPLANTATION IN ADULT PHI NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Background:Acute lymphoblastic leukemia (ALL) is a rare disease in adults. Despite the novels therapies, clinical outcomes remain unsatisfactory. Bone marrow allograft still holds ...
Perioperative Acute Renal Injury: Revisiting Pathophysiology
Perioperative Acute Renal Injury: Revisiting Pathophysiology
Background
Acute renal dysfunction and subsequent acute renal failure after cardiac surgery are associated with high mortality and morbidity. Early therapeutic or preve...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Interpretation of orthotopic liver transplantation biopsy
Interpretation of orthotopic liver transplantation biopsy
Liver transplantation is an established treatment for various forms of severe liver disease due to any etiology, as well as selected metabolic and neoplastic conditions. Exposure t...

